ArticleInternational journal for numerical methods in biomedical engineering2026
A Real-Time Digital Twin for Human Cardiovascular Applications.
Article in International journal for numerical methods in biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital twin (DT) technology is revolutionizing various industries and has immense potential in healthcare as well. A human DT is a virtual representation of an individual patient, capable of mimicking the current (patho)physiological state and predicting future states, making it ideal for supporting clinical decision-making. A DT combines a mathematical model with real-time data; however, its development remains challenging. It must estimate a unique parameter value whenever a measurement becomes available, enabling real-time tracking of parameter change, while preserving model stability. The DT was designed based on a reduced-order unscented Kalman filter (ROUKF), using a lumped-parameter model of the systemic circulation, to estimate left ventricular contractility. This DT was evaluated using both synthetic and in vivo left ventricle pressure data, the latter collected by Johnson et al. Synthetic data were used for local sensitivity, identifiability, and stability analysis, as well as to evaluate the DTs performance. In vivo data were used to evaluate the DTs potential for future clinical application. The DT estimated the true parameter in real-time, remained robust to measurement noise, and tracked parameter changes independent of initial conditions. The parameter estimate was identifiable despite measurement noise, and the mathematical model proved stable within a physiologically realistic range. Application to in vivo data demonstrated successful tracking of inotropic state changes, with the estimated parameter showing a strong correlation with the conventional contractility proxy (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.